
    
      Pediatric patients (age 12 to 18 inclusive) with a diagnosis of multiple sclerosis, ADEM,
      anti-MOG mediated demyelinating disease as well as healthy controls will be recruited to
      undergo clinical testing. The study visits will include neuropsychological testing, optical
      coherence tomography (OCT) and MRI on both the 3T and 7T magnet. Subjects will be asked to
      undergo two study visits separated by 12 months +/- 2 months. Each study visit will have the
      same neuropsychological, OCT, and research MRI examinations.
    
  